ICU Medical, Inc. ICUI
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.37% | 0.51% | -12.32% | -14.15% | -8.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.37% | 0.51% | -12.32% | -14.15% | -8.85% |
| Cost of Revenue | -0.01% | -1.55% | -17.89% | -16.10% | -12.54% |
| Gross Profit | 11.69% | 3.89% | -1.85% | -10.68% | -1.94% |
| SG&A Expenses | 1.07% | -4.69% | -1.70% | -1.91% | -6.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.41% | -2.28% | -13.09% | -11.84% | -10.19% |
| Operating Income | 79.44% | 54.93% | 2.69% | -43.36% | 27.18% |
| Income Before Tax | 939.66% | -28.37% | 57.99% | -323.77% | 77.39% |
| Income Tax Expenses | 1,193.16% | 500.17% | -859.61% | -108.28% | -104.37% |
| Earnings from Continuing Operations | 890.55% | -45.99% | 294.70% | 33.97% | 89.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 890.55% | -45.99% | 294.70% | 33.97% | 89.70% |
| EBIT | 79.44% | 54.93% | 2.69% | -43.36% | 27.18% |
| EBITDA | 25.92% | 19.19% | 1.74% | -22.34% | 1.13% |
| EPS Basic | 880.23% | -46.75% | 292.93% | 34.49% | 89.81% |
| Normalized Basic EPS | 263.80% | 161.85% | 105.40% | -74.07% | 251.54% |
| EPS Diluted | 864.29% | -46.85% | 290.26% | 35.06% | 89.63% |
| Normalized Diluted EPS | 261.82% | 162.04% | 101.98% | -74.07% | 251.54% |
| Average Basic Shares Outstanding | 1.30% | 1.44% | 0.92% | 0.80% | 1.01% |
| Average Diluted Shares Outstanding | 1.86% | 1.36% | 2.62% | 0.80% | 1.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |